Brincidofovir is highly efficacious in controlling adenoviremia in pediatric recipients of hematopoietic cell transplant

View/ Open
Date
2017-04-06ICR Author
Author
Hiwarkar, P
Amrolia, P
Sivaprakasam, P
Lum, SH
Doss, H
O’Rafferty, C
Petterson, T
Patrick, K
Silva, J
Slatter, M
Lawson, S
Rao, K
Steward, C
Gassas, A
Veys, P
Wynn, R
Type
Journal Article
Metadata
Show full item recordAbstract
Key Points Brincidofovir has superior antiadenoviral activity and safety profile compared with cidofovir. Brincidofovir is highly efficacious in controlling adenoviremia during the lymphopenic phase of HCT.
Collections
Language
eng
License start date
2017-04-06
Citation
Blood, 2017, 129 (14), pp. 2033 - 2037
Publisher
American Society of Hematology